Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 6, 2007, Pages 910-919

  Rocha Singh, Krishna J ^a   Jaff, Michael R ^b   Crabtree, Tami R ^e   Bloch, Daniel A ^c   Ansel, Gary ^d  

^a Prairie Vascular Institute   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c STANFORD UNIVERSITY   (United States)

^d Riverside Hospital   (United States)

^e NONE

Author keywords

Femoropoplitsal artery; Nitinol stents; Percutaneous transluminal angioplasty, intermittent claudication; Peripheral arterial disease; Stenting

Indexed keywords

NITINOL;

ADULT; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; POPLITEAL ARTERY; RANDOMIZED CONTROLLED TRIAL; SAFETY; STENT; TREATMENT OUTCOME;

ALLOYS; ANGIOPLASTY, BALLOON; ATHEROSCLEROSIS; CLINICAL TRIALS; ENDPOINT DETERMINATION; FEMORAL ARTERY; GUIDELINES; HUMANS; INTERMITTENT CLAUDICATION; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; REGISTRIES; RESEARCH DESIGN; SAMPLE SIZE; SEVERITY OF ILLNESS INDEX; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULAR SURGICAL PROCEDURES;

EID: 34249910647     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21104     Document Type: Article

References (21)

1. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association of Vascular Surgery/Society of Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology. Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006;47:1239-1312.
2. Smith SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung and Blood Institute. Circulation 2006; 47:2130-2139.
3. Pokrajac B, Potter R, Wolfram R, et al. Endovascular brachytherapy prevents restenosis after femoro-popliteal angioplasty: Results of the Vienna-3 randomised multi-center study. Radiotherapy and Oncology 2005;74:3-9.
4. van der Zaag ES, Legemate DA, Prins MH, et al. Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc Surg 2004;28:132-137.
5. Becquemin JP, Favre JP, Marzelle J. et al. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: A multicenter prospective randomized study. J Vasc Surg 2003;37:487-494.
6. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent placement in femoro-popliteal artery obstructions: A multi-center prospective randomized study. J Vasc Interv Radiol 2001;12:23-31.
7. Minar E, Pokrajac B, Maca T, et al. Endovascular brachytherapy for prophylaxis of restenosis after femoro-popliteal angioplasty: Results of a prospective randomized study. Circulation 2000;102:2694-2699.
8. Zdanowski Z, Albrechtsson U, Lundin A, et al. Percutaneous transluminal angioplasty with or without stenting for femoro-popliteal occlusions? A randomized controlled study. Int Angiol 1999;18:251-255.
9. Vroegindeweij D, Vos L, Tieelbeek A, et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoro-popliteal obstructions: A comparative randomized study. Cardiovasc Interv Radiol 1997;20:420-425.
10. Whyman MR, Fowkes FGR, Kerracher EMG, et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. Eur J Vasc Endovasc Surg 1996;12:167-172.
11. Tielbeek A, Vroegindeweij D, Buth J, et al. Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoro-popliteal artery: angiographic and clinical results of a prospective randomized trial. J Vasc Interv Radiol 1996;7:837-844.
12. Holm J, Arfvidsson B, Jivegard L, et al. Chronic lower limb ischemia. A prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur J Vasc Surg 1991;5:517-522.
13. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-1888.
14. Agresti A Coull B. Approximate is better than "exact" for interval estimation of binominal proportions. Am Stat 1998;2:119-125.
15. Duda S, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: The SIROCCO II trial. J Vasc Interv Radiol 2005;16:331-338.
16. Ansel G, Silver M, Botti C, et al. Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease. Catheter Cardiovasc Interv 2006;67:288-297.
17. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six-month results. Circulation 2002;106:1505-1509.
18. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fracture after femoro-popliteal stenting. J Am Coll Cardiol 2005;45:312-315.
19. Hiatt WR, Hirsh AT, Regensteiner JG, et al. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical endpoints. Vasc Clin Trialists Circulation 1995;92:614-621.
20. Kohler T, Nance D, Cramer M, Vandenburghe N, Strandness D. Duplex scanning for diagnosis of aortoiliac and femoropopliteal disease: A prospective study. Circulation 1987;76:1074-1080.
21. Sabeti S, Schillinger M, Amighi J, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: Propensity score-adjusted analysis. Radiology 2004;232:516-521.